Ralph Scully, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Replication | 16 | 2022 | 1399 | 3.710 |
Why?
|
| DNA Breaks, Double-Stranded | 25 | 2022 | 594 | 3.260 |
Why?
|
| DNA Repair | 27 | 2022 | 2046 | 2.900 |
Why?
|
| BRCA1 Protein | 20 | 2021 | 1149 | 2.250 |
Why?
|
| Chromatids | 7 | 2017 | 63 | 1.690 |
Why?
|
| Recombination, Genetic | 16 | 2021 | 1586 | 1.660 |
Why?
|
| Gene Conversion | 6 | 2016 | 71 | 1.560 |
Why?
|
| Rad51 Recombinase | 8 | 2018 | 189 | 1.560 |
Why?
|
| BRCA2 Protein | 8 | 2021 | 794 | 1.360 |
Why?
|
| DNA-Binding Proteins | 20 | 2021 | 9648 | 1.270 |
Why?
|
| DNA Helicases | 4 | 2021 | 859 | 1.220 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2021 | 486 | 1.170 |
Why?
|
| Histones | 10 | 2017 | 2599 | 1.170 |
Why?
|
| Genomic Instability | 10 | 2019 | 695 | 1.110 |
Why?
|
| Sister Chromatid Exchange | 4 | 2011 | 60 | 0.990 |
Why?
|
| Chromosomes | 3 | 2022 | 596 | 0.850 |
Why?
|
| Chromatin | 8 | 2022 | 2934 | 0.850 |
Why?
|
| Escherichia coli Proteins | 3 | 2021 | 1050 | 0.850 |
Why?
|
| DNA Damage | 16 | 2021 | 2432 | 0.820 |
Why?
|
| Tandem Repeat Sequences | 2 | 2018 | 185 | 0.720 |
Why?
|
| Fanconi Anemia | 1 | 2022 | 319 | 0.710 |
Why?
|
| DNA Repair Enzymes | 3 | 2021 | 349 | 0.580 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2016 | 26 | 0.570 |
Why?
|
| Genes, BRCA1 | 6 | 2018 | 781 | 0.530 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 4 | 2017 | 170 | 0.510 |
Why?
|
| Radiation, Ionizing | 4 | 2017 | 258 | 0.490 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2017 | 736 | 0.450 |
Why?
|
| Ovarian Neoplasms | 6 | 2017 | 4838 | 0.440 |
Why?
|
| Multienzyme Complexes | 1 | 2016 | 686 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 2849 | 0.390 |
Why?
|
| Escherichia coli | 2 | 2021 | 4217 | 0.370 |
Why?
|
| Embryonic Stem Cells | 4 | 2017 | 1294 | 0.370 |
Why?
|
| Animals | 38 | 2022 | 168757 | 0.370 |
Why?
|
| Mice | 25 | 2022 | 81183 | 0.360 |
Why?
|
| Endonucleases | 2 | 2022 | 380 | 0.350 |
Why?
|
| S Phase | 4 | 2017 | 423 | 0.340 |
Why?
|
| Breast Neoplasms | 9 | 2016 | 20822 | 0.340 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 365 | 0.330 |
Why?
|
| Cell Line | 12 | 2021 | 15997 | 0.330 |
Why?
|
| Cell Cycle | 2 | 2021 | 2967 | 0.320 |
Why?
|
| Eukaryotic Cells | 1 | 2009 | 198 | 0.320 |
Why?
|
| Lysine | 1 | 2012 | 1007 | 0.310 |
Why?
|
| Gammaherpesvirinae | 1 | 2007 | 27 | 0.310 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 2915 | 0.310 |
Why?
|
| Aneuploidy | 1 | 2010 | 530 | 0.300 |
Why?
|
| Genes, Reporter | 4 | 2017 | 1547 | 0.300 |
Why?
|
| Nuclear Proteins | 6 | 2016 | 5853 | 0.290 |
Why?
|
| DNA | 7 | 2022 | 7301 | 0.280 |
Why?
|
| Carrier Proteins | 4 | 2016 | 5021 | 0.280 |
Why?
|
| Exodeoxyribonucleases | 2 | 2021 | 180 | 0.270 |
Why?
|
| Sequence Deletion | 2 | 2022 | 1526 | 0.270 |
Why?
|
| Cell Cycle Proteins | 6 | 2014 | 3462 | 0.260 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3772 | 0.250 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2014 | 440 | 0.230 |
Why?
|
| Genes, BRCA2 | 2 | 2004 | 618 | 0.230 |
Why?
|
| Green Fluorescent Proteins | 4 | 2011 | 2088 | 0.230 |
Why?
|
| Micrococcal Nuclease | 1 | 2022 | 37 | 0.220 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2010 | 990 | 0.220 |
Why?
|
| Introns | 1 | 2005 | 991 | 0.210 |
Why?
|
| Lamin Type B | 1 | 2021 | 25 | 0.200 |
Why?
|
| Replication Protein A | 3 | 2017 | 52 | 0.200 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2005 | 671 | 0.200 |
Why?
|
| Transfection | 3 | 2021 | 5892 | 0.200 |
Why?
|
| Mutation | 13 | 2021 | 29786 | 0.190 |
Why?
|
| Serine | 1 | 2004 | 826 | 0.190 |
Why?
|
| Cells, Cultured | 7 | 2021 | 19229 | 0.190 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2021 | 148 | 0.190 |
Why?
|
| Flow Cytometry | 3 | 2021 | 5974 | 0.180 |
Why?
|
| Fibroblasts | 5 | 2021 | 4161 | 0.180 |
Why?
|
| Crossing Over, Genetic | 2 | 2013 | 95 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2022 | 893 | 0.170 |
Why?
|
| Virus Replication | 1 | 2007 | 2534 | 0.170 |
Why?
|
| Ubiquitination | 2 | 2021 | 1012 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2017 | 50 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2009 | 5179 | 0.150 |
Why?
|
| Clone Cells | 1 | 2021 | 1692 | 0.150 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2017 | 100 | 0.150 |
Why?
|
| Protein Binding | 7 | 2021 | 9386 | 0.150 |
Why?
|
| Gene Duplication | 1 | 2018 | 329 | 0.150 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 154 | 0.150 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2016 | 19 | 0.140 |
Why?
|
| Models, Biological | 5 | 2016 | 9583 | 0.140 |
Why?
|
| Oncogene Proteins | 2 | 2018 | 749 | 0.140 |
Why?
|
| Nucleosides | 1 | 2016 | 138 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 2 | 2016 | 165 | 0.130 |
Why?
|
| Erythroid Cells | 1 | 2017 | 238 | 0.130 |
Why?
|
| Humans | 44 | 2021 | 744343 | 0.130 |
Why?
|
| Protein Subunits | 2 | 2015 | 959 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 1861 | 0.120 |
Why?
|
| Cell Line, Tumor | 10 | 2021 | 16689 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2010 | 2916 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2016 | 500 | 0.120 |
Why?
|
| Cricetinae | 2 | 2009 | 2472 | 0.120 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2013 | 23 | 0.120 |
Why?
|
| HeLa Cells | 5 | 2021 | 3128 | 0.110 |
Why?
|
| Cricetulus | 2 | 2017 | 816 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2015 | 8436 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17446 | 0.110 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 562 | 0.100 |
Why?
|
| Plasmids | 2 | 2009 | 2307 | 0.100 |
Why?
|
| CHO Cells | 2 | 2017 | 1406 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 1465 | 0.100 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 173 | 0.090 |
Why?
|
| Protein Transport | 2 | 2014 | 1988 | 0.090 |
Why?
|
| Hydroxyurea | 1 | 2011 | 290 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 279 | 0.090 |
Why?
|
| Methylation | 1 | 2012 | 1106 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2021 | 12208 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 3505 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 670 | 0.080 |
Why?
|
| Lasers | 1 | 2012 | 952 | 0.080 |
Why?
|
| Exons | 1 | 2014 | 2437 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2009 | 682 | 0.080 |
Why?
|
| DNA, Single-Stranded | 2 | 2021 | 354 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 1060 | 0.070 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 1353 | 0.070 |
Why?
|
| Female | 17 | 2020 | 380194 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 981 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 1990 | 0.070 |
Why?
|
| Binding Sites | 2 | 2013 | 6114 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2013 | 3494 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2503 | 0.070 |
Why?
|
| Homozygote | 1 | 2010 | 1785 | 0.070 |
Why?
|
| Sirtuins | 1 | 2008 | 323 | 0.070 |
Why?
|
| Herpesviridae Infections | 1 | 2007 | 277 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9734 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2017 | 1888 | 0.060 |
Why?
|
| Kinetics | 1 | 2012 | 6473 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3701 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2017 | 14557 | 0.060 |
Why?
|
| Open Reading Frames | 1 | 2007 | 810 | 0.060 |
Why?
|
| Mammals | 1 | 2009 | 1143 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2203 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2011 | 2187 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 2025 | 0.050 |
Why?
|
| Histone Chaperones | 2 | 2014 | 76 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2003 | 187 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2440 | 0.050 |
Why?
|
| Multiprotein Complexes | 2 | 2021 | 1119 | 0.050 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 42 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 1726 | 0.050 |
Why?
|
| Alleles | 1 | 2013 | 6933 | 0.050 |
Why?
|
| Gene Amplification | 1 | 2005 | 1063 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2699 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2010 | 2924 | 0.040 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2020 | 105 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2007 | 1900 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 13815 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 704 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2015 | 2256 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 936 | 0.040 |
Why?
|
| Cyclin E | 1 | 2018 | 172 | 0.040 |
Why?
|
| Phthalazines | 1 | 2020 | 363 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 18111 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2003 | 1117 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2002 | 587 | 0.040 |
Why?
|
| Gene Knockout Techniques | 2 | 2011 | 809 | 0.040 |
Why?
|
| Chromosome Pairing | 1 | 2016 | 47 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 3129 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2018 | 755 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11524 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 130 | 0.030 |
Why?
|
| DNA Ligases | 1 | 2015 | 80 | 0.030 |
Why?
|
| Base Sequence | 2 | 2003 | 12797 | 0.030 |
Why?
|
| Pedigree | 1 | 2003 | 4644 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5221 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2015 | 177 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 214 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1866 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 411 | 0.030 |
Why?
|
| Thymine Nucleotides | 1 | 2013 | 63 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2021 | 4011 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 192 | 0.030 |
Why?
|
| Morpholines | 1 | 2016 | 571 | 0.030 |
Why?
|
| Interphase | 1 | 2013 | 226 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 557 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2016 | 542 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 641 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 457 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2012 | 117 | 0.030 |
Why?
|
| Replication Protein C | 1 | 2011 | 19 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 474 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2017 | 1166 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1878 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 365 | 0.020 |
Why?
|
| RecQ Helicases | 1 | 2011 | 54 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.020 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2011 | 65 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1758 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2716 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 12072 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 7722 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 386 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2015 | 1539 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2011 | 184 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2016 | 1538 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2011 | 320 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 611 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 8664 | 0.020 |
Why?
|
| Phenotype | 2 | 2018 | 16365 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2634 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 21683 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 40075 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3567 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13102 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 226 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10481 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1792 | 0.020 |
Why?
|
| Camptothecin | 1 | 2011 | 576 | 0.020 |
Why?
|
| Yeasts | 1 | 2008 | 285 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 880 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1706 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2008 | 246 | 0.020 |
Why?
|
| Telomerase | 1 | 2012 | 730 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 1808 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 910 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 2008 | 268 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5456 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 3002 | 0.020 |
Why?
|
| Metabolomics | 1 | 2013 | 1484 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2889 | 0.020 |
Why?
|
| Genome, Human | 1 | 2016 | 4420 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 2938 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5097 | 0.010 |
Why?
|
| Protein Phosphatase 2 | 1 | 2003 | 229 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13695 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 337 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4204 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3798 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.010 |
Why?
|
| Lymphoma | 1 | 2008 | 1877 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21827 | 0.010 |
Why?
|
| Male | 3 | 2020 | 350118 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2892 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3086 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5720 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 1783 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2002 | 1189 | 0.010 |
Why?
|
| Breast | 1 | 2003 | 1969 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2969 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 2460 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2002 | 6544 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10180 | 0.000 |
Why?
|
| Brain | 1 | 2008 | 26385 | 0.000 |
Why?
|